日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Jak3 deficiency blocks innate lymphoid cell development

Jak3 缺乏阻碍先天淋巴细胞发育

M L Robinette, M Cella, J B Telliez, T K Ulland, A D Barrow, K Capuder, S Gilfillan, L-L Lin, L D Notarangelo, M Colonna

Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis

患有噬血细胞性淋巴组织细胞增生症的儿童和年轻成人患者中发现新的 Munc13-4 突变

A Santoro, S Cannella, G Bossi, F Gallo, A Trizzino, D Pende, F Dieli, G Bruno, J C Stinchcombe, C Micalizzi, C De Fusco, C Danesino, L Moretta, L D Notarangelo, G M Griffiths, M Aricò

X-chromosome inactivation analysis in a female carrier of FOXP3 mutation

FOXP3 突变女性携带者的 X 染色体失活分析

A Tommasini, S Ferrari, D Moratto, R Badolato, M Boniotto, D Pirulli, L D Notarangelo, M Andolina

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease

NTB-A [GNTB-A 的修正],一种新型 SH2D1A 相关表面分子,导致自然杀伤细胞无法杀死 X 连锁淋巴增生性疾病中受 Epstein-Barr 病毒感染的 B 细胞

C Bottino, M Falco, S Parolini, E Marcenaro, R Augugliaro, S Sivori, E Landi, R Biassoni, L D Notarangelo, L Moretta, A Moretta

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

连锁淋巴增生性疾病。2B4 分子表现出抑制功能而非激活功能,导致自然杀伤细胞无法杀死 Epstein-Barr 病毒感染的细胞

S Parolini, C Bottino, M Falco, R Augugliaro, S Giliani, R Franceschini, H D Ochs, H Wolf, J Y Bonnefoy, R Biassoni, L Moretta, L D Notarangelo, A Moretta